N. Sharda

Determination of rifampicin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC method.

R. Panchagnula, A. Sood, N. Sharda, 1999, Journal of pharmaceutical and biomedical analysis.

Establishment of inherent stability of stavudine and development of a validated stability-indicating HPLC assay method.

Baljinder Singh, Saranjit Singh, N. Sharda, 2005, Journal of pharmaceutical and biomedical analysis.

Evaluation of the recently reported USP gradient HPLC method for analysis of anti-tuberculosis drugs for its ability to resolve degradation products of rifampicin.

Saranjit Singh, N. Sharda, B. Mohan, 2003, Journal of pharmaceutical and biomedical analysis.

Behavior of Decomposition of Rifampicin in the Presence of Isoniazid in the pH Range 1–3

Saranjit Singh, N. Sharda, R. Sankar, 2003, Drug development and industrial pharmacy.

Validated specific HPLC method for determination of zidovudine during stability studies.

Baljinder Singh, Saranjit Singh, N. Sharda, 2005, Journal of pharmaceutical and biomedical analysis.

Spectrophotometric determination of pKa of nimesulide

Saranjit Singh, N. Sharda, L. Mahajan, 1999 .

The Reason for an Increase in Decomposition of Rifampicin in the Presence of Isoniazid under Acid Conditions

A. Chakraborti, Sanjeev Kumar, Saranjit Singh, 2000 .

Degradation of Rifampicin, Isoniazid and Pyrazinamide from Prepared Mixtures and Marketed Single and Combination Products Under Acid Conditions

Baljinder Singh, Saranjit Singh, T. Mariappan, 2000 .

New findings on degradation of famotidine under basic conditions: identification of a hitherto unknown degradation product and the condition for obtaining the propionamide intermediate in pure form.

A. Chakraborti, Sanjeev Kumar, Saranjit Singh, 2002, Journal of Pharmacy and Science.